Reducing child deaths
from pneumonia in Ethiopia
Pneumonia is the leading infectious killer of children under 5, globally. In Ethiopia, the burden of disease is especially high, even though an effective treatment exists (amoxicillin dispersible tablets (amox DT)).
In 2015, with support from the Bill & Melinda Gates Foundation, R4D began working with the government of Ethiopia to address an urgent challenge — an impending funding cliff for amox DT as previous donors significantly reduced or closed out their programs.
R4D supported the government to mobilize catalytic funding from a new donor to ensure uninterrupted supply to public health facilities, and then worked quickly to understand the root causes of the situation. Then, R4D collaborated with government partners to co-create market shaping solutions and support efforts to holistically strengthen capacities throughout the entire system — including improving methodologies to more accurately predict demand for the drug, strengthening government procurement capacities, updating treatment guidelines, mobilizing domestic funding, working with manufacturers to increase supply security and more.